• Explore /
  • Poster
  • / CA209-9KY: Results of a phase II study of intensity modulated radiotherapy (IMRT) re-irradiation and concurrent/adjuvant nivolumab (nivo) in patients with loco-regionally recurrent or second primary (RSPT) head and neck squamous cell carcinoma (HNSCC).

CA209-9KY: Results of a phase II study of intensity modulated radiotherapy (IMRT) re-irradiation and concurrent/adjuvant nivolumab (nivo) in patients with loco-regionally recurrent or second primary (RSPT) head and neck squamous cell carcinoma (HNSCC).

Abstract Poster

Authors

Nabil Saba

Nabil F. Saba

Winship Cancer Institute Emory University School of Medicine, Atlanta, GA

Nabil F. Saba , Mark William McDonald , Ashley McCook-Veal , William A. Stokes , Tahseen Nasti , Soumon Rudra , James Edward Bates , Jill Remick , Nikhil Joshi , Neil McIver Woody , Jessica Lyn Geiger , Musaddiq Awan , Aditya V. Shreenivas , Kristin Ann Higgins , Conor Ernst Steuer , Rafi Ahmed , Dong Moon Shin , Yuan Liu , Stuart J. Wong , Shlomo A. Koyfman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT03521570

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 6029)

DOI

10.1200/JCO.2022.40.16_suppl.6029

Abstract #

6029

Poster Bd #

21

Abstract Disclosures

Similar Posters

First Author: Christine H. Chung

First Author: Douglas Adkins

First Author: Colette Shen

First Author: Suzanne Phillips